Default company panoramic image

Tetra Discovery Partners

Tetra Designs Drugs To Treat Memory Loss

  • Stage Product In Development
  • Industry Biotechnology
  • Location Grand Rapids, MI, USA
  • Currency USD
  • Founded November 2010
  • Employees 4
  • Website

Company Summary

Tetra Discovery Partners designs drugs to treat memory loss by improving how the brain processes and stores information. This is potentially breakthrough technology that will improve the quality of life in patients suffering from Alzheimer's disease, traumatic brain injury, and depression. Tetra is led by Dr. Mark Gurney PhD MBA, a seasoned pharmaceutical research and business executive with 20+ years experience in industry and academia.


  • Default avatar
    Mark Gurney
    Chairman & CEO

    Mark Gurney received his PhD from Caltech and his MBA from Kellogg. He was on the faculty of The University of Chicago and Northwestern University, was Director, Genomics Research at Pharmacia Upjohn and Senior Vice President of Drug Discovery and Development for deCODE genetics. He has published 116 peer-reviewed articles which have over 16,000 citations. He holds 35 patents and was named a leading inventor for Alzheimer’s therapeutics.

  • Default avatar
    Eric Nelson
    Business Development

    Eric Nelson, PhD is a business development consultant to the NINDS Office of Translational Research program. He assists NINDS-funded PIs in making sure that ther drug projects are ready for industry partnerships. Before working with the NINDS he was a consultant with the NCATS Therapeutics for Rare & Neglected Diseases (TRND) program, helping to build the overall program and assemble a pipeline of 15 drugs for rare and neglected diseases. Previou


  • Default avatar
    Harvey Koning, Varnum
    Default avatar
    Mark Taylor, Rehmann

Previous Investors

  • Default avatar
    Grand Angels
    Default avatar
    Trout Creek Ventures
    Default avatar